Literature DB >> 26419981

[Guideline on the diagnosis and therapy of ST-segment elevation myocardial infarction].

.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26419981

Source DB:  PubMed          Journal:  Zhonghua Xin Xue Guan Bing Za Zhi        ISSN： 0253-3758


× No keyword cloud information.
  18 in total

1.  The Predictive Value of Myeloperoxidase for Contrast-Induced Nephropathy After Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction.

Authors:  Gaoliang Yan; Chengchun Tang; Genshan Ma
Journal:  Int J Gen Med       Date:  2021-04-30

2.  Risk stratification of ST-segment elevation myocardial infarction (STEMI) patients using machine learning based on lipid profiles.

Authors:  Yuzhou Xue; Jian Shen; Weifeng Hong; Wei Zhou; Zhenxian Xiang; Yuansong Zhu; Chuiguo Huang; Suxin Luo
Journal:  Lipids Health Dis       Date:  2021-05-06       Impact factor: 3.876

3.  Total ischemic time and outcomes for patients with ST-elevation myocardial infarction: does time of admission make a difference?

Authors:  Jun-Xian Song; Li Zhu; Chong-You Lee; Hui Ren; Cheng-Fu Cao; Hong Chen
Journal:  J Geriatr Cardiol       Date:  2016-08       Impact factor: 3.327

Review 4.  Prevalence of cardiovascular medication on secondary prevention after myocardial infarction in China between 1995-2015: A systematic review and meta-analysis.

Authors:  Min Zhao; Kerstin Klipstein-Grobusch; Xin Wang; Johannes B Reitsma; Dong Zhao; Diederick E Grobbee; Ian Graham; Ilonca Vaartjes
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

Review 5.  Nicorandil prior to primary percutaneous coronary intervention improves clinical outcomes in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.

Authors:  Li Xu; Lefeng Wang; Kuibao Li; Zhiyong Zhang; Hao Sun; Xinchun Yang
Journal:  Drug Des Devel Ther       Date:  2019-04-29       Impact factor: 4.162

6.  A retrospective cohort study of oral anticoagulant treatment in patients with acute coronary syndrome and atrial fibrillation.

Authors:  Linlin Mai; Yu Wu; Jianjing Luo; Xinyue Liu; Hailan Zhu; Haoxiao Zheng; Guoquan Liang; Yan Zhang; Yuli Huang
Journal:  BMJ Open       Date:  2019-09-17       Impact factor: 2.692

7.  Protocol of the China ST-segment elevation myocardial infarction (STEMI) Care Project (CSCAP): a 10-year project to improve quality of care by building up a regional STEMI care network.

Authors:  Yan Zhang; Bo Yu; Yaling Han; Jianan Wang; Lixia Yang; Zheng Wan; Zheng Zhang; Yuguo Chen; Xianghua Fu; Chuanyu Gao; Bao Li; Jiyan Chen; Ming Wu; Yitong Ma; Xingsheng Zhao; Yundai Chen; Hongbing Yan; Dingcheng Xiang; Weiyi Fang; Sameer Mehta; Christoph K Naber; Junbo Ge; Yong Huo
Journal:  BMJ Open       Date:  2019-07-17       Impact factor: 2.692

8.  Three-dimensional quantitative assessment of myocardial infarction via multimodality fusion imaging: methodology, validation, and preliminary clinical application.

Authors:  Zhenzhen Xu; Bo Tao; Chuanbin Liu; Dong Han; Jibin Zhang; Junsong Liu; Sulei Li; Weijie Li; Jing Wang; Jimin Liang; Feng Cao
Journal:  Quant Imaging Med Surg       Date:  2021-07

9.  Readily accessible risk model to predict in-hospital major adverse cardiac events in patients with acute myocardial infarction: a retrospective study of Chinese patients.

Authors:  Xiaoxia Hou; Xin Du; Guohong Wang; Xiaoyan Zhao; Yang Zheng; Yingxue Li; Eryu Xia; Yong Qin; Jianzeng Dong; Chang-Sheng Ma
Journal:  BMJ Open       Date:  2021-07-01       Impact factor: 2.692

10.  Safety and Incidence of Cardiovascular Events in Chinese Patients with Acute Coronary Syndrome Treated with Ticagrelor: the 12-Month, Phase IV, Multicenter, Single-Arm DAYU Study.

Authors:  Runlin Gao; Yongjian Wu; Hengliang Liu; Guohai Su; Zuyi Yuan; Aidong Zhang; Yong Wang; Zhirong Wang; Yan Wang; Huanyi Zhang; Yang Zheng; Lei Liu; Lijun Shen; Maria Leonsson-Zachrisson; Yaling Han
Journal:  Cardiovasc Drugs Ther       Date:  2018-02       Impact factor: 3.727
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.